Live from the NIH registry
Studies recruiting near Jackson right now
Top 25 of 224 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Relay Therapeutics, Inc.
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
Tibial Fractures, Pain
Phase 3
Interventional 1,000 participants sought
University of Mississippi — Jackson, Mississippi (2.0 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Mississippi Retina Associates — Madison, Mississippi (11.6 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation
Anterior Cruciate Ligament Reconstruction Rehabilitation
N/A
Interventional 15 participants sought
The University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: University of Mississippi Medical Center
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prostate Cancer
Phase 4
Interventional 700 participants sought
University of Mississippi Med Ctr — Jackson, Mississippi (2.0 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
SKY Integrative Medical Center — Ridgeland, Mississippi (9.1 mi)
· Sponsor: Organon and Co
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Proven Endpoints LLC /ID# 258066 — Ridgeland, Mississippi (9.1 mi)
· Sponsor: AbbVie
Intervention to Enhance PrEP Persistence
HIV Prevention, HIV Infection Primary
N/A
Interventional 300 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Brown University
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF)
N/A
Observational 60 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: University of Mississippi Medical Center
Prescription of Letrozole for Uterine Myoma
Leiomyoma, Uterine, Leiomyoma
Phase 4
Interventional 140 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: University of California, San Francisco
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
Post-ligation Cardiac Syndrome
Phase 3
Interventional 316 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: NICHD Neonatal Research Network
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt
Right-To-Left Shunt
Phase 3
Interventional 300 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: Agitated Solutions, Inc.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Gastrointestinal Associates Research — Flowood, Mississippi (4.3 mi)
· Sponsor: Hoffmann-La Roche
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Precise Research Centers — Flowood, Mississippi (4.3 mi)
· Sponsor: Bristol-Myers Squibb
Pivotal Study of Voro Urologic Scaffold
Radical Prostatectomy, Stress Urinary Incontinence (SUI)
Phase 3
Interventional 266 participants sought
BMHCC/ Mississippi Urology Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: Levee Medical, Inc.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
Lung Cancer Screening
N/A
Interventional 200 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Timothy Mullett
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 2
Interventional 405 participants sought
Oscar Clinical Trials — Jackson, Mississippi (2.0 mi)
· Sponsor: Boehringer Ingelheim
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
St. Dominic's Hospital ( Site 5004) — Jackson, Mississippi (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
Phase 3
Interventional 130 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: PedAL BCU, LLC
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 216 — Jackson, Mississippi (2.0 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Children's Oncology Group
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Children's Oncology Group